Expedia, Inc. (EXPE) Forms $133.31 Double Bottom; Omega Protein (OME) Sentiment Is 0.87

Expedia, Inc. (EXPE) formed double bottom with $121.31 target or 9.00% below today’s $133.31 share price. Expedia, Inc. (EXPE) has $20.33 billion valuation. The stock increased 0.71% or $0.945 during the last trading session, reaching $133.305. About 306,955 shares traded. Expedia, Inc. (NASDAQ:EXPE) has risen 30.43% since January 16, 2017 and is uptrending. It has outperformed by 13.73% the S&P500.

Omega Protein Corporation develops, produces, and delivers products to enhance the nutritional integrity of foods, dietary supplements, and animal feeds worldwide. The company has market cap of $494.54 million. It operates in two divisions, Animal Nutrition and Human Nutrition. It has a 26.8 P/E ratio. The Animal Nutrition segment produces animal nutrition products, including fish meal products that are primarily used as a protein ingredient in animal feed for swine, aquaculture, and household pets.

The stock increased 0.23% or $0.05 during the last trading session, reaching $22. About 658,975 shares traded or 23.41% up from the average. Omega Protein Corporation (OME) has declined 0.60% since January 16, 2017 and is downtrending. It has underperformed by 17.30% the S&P500.

Wynnefield Capital Inc holds 1.58% of its portfolio in Omega Protein Corporation for 265,108 shares. Euclidean Technologies Management Llc owns 65,153 shares or 1.04% of their US portfolio. Moreover, Thomson Horstmann & Bryant Inc has 0.79% invested in the company for 347,088 shares. The Illinois-based Perritt Capital Management Inc has invested 0.39% in the stock. Snow Capital Management Lp, a Pennsylvania-based fund reported 283,560 shares.

Among 36 analysts covering Expedia Inc. (NASDAQ:EXPE), 27 have Buy rating, 0 Sell and 9 Hold. Therefore 75% are positive. Expedia Inc. has $190 highest and $27 lowest target. $150.25’s average target is 12.71% above currents $133.305 stock price. Expedia Inc. had 106 analyst reports since July 24, 2015 according to SRatingsIntel. Stifel Nicolaus upgraded Expedia, Inc. (NASDAQ:EXPE) on Friday, January 6 to “Buy” rating. On Tuesday, July 25 the stock rating was maintained by Credit Suisse with “Buy”. The firm earned “Overweight” rating on Friday, October 27 by Barclays Capital. Argus Research downgraded the stock to “Hold” rating in Tuesday, December 5 report. The firm earned “Neutral” rating on Friday, October 27 by Credit Suisse. The firm has “Buy” rating given on Wednesday, January 10 by Morgan Stanley. The firm has “Hold” rating given on Friday, July 28 by Jefferies. The rating was maintained by Barclays Capital with “Overweight” on Friday, July 29. The firm has “Outperform” rating given on Thursday, November 5 by Oppenheimer. The stock of Expedia, Inc. (NASDAQ:EXPE) has “Outperform” rating given on Friday, July 31 by RBC Capital Markets.